Related Experiment Video

Updated: Jul 31, 2025

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
12:39

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

Published on: June 24, 2011

38.3K

Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional

Claudio U Köser1, Florian P Maurer2

  • 1Department of Genetics, University of Cambridge, Cambridge, UK cuk21@cam.ac.uk.

The European Respiratory Journal
|May 5, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

10.5K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K

Related Experiment Videos

Last Updated: Jul 31, 2025

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
12:39

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

Published on: June 24, 2011

38.3K
Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

10.5K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K

Related Concept Videos

Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

60
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
60

Articles linked to this work by shared authors, journal, and citation graph.

Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.

Microbiology spectrum·2026

In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy·2025

The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy·2025

Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis-An ESGMYC collaborative study.

PloS one·2024

The exceptions that prove the rule-a historical view of bedaquiline susceptibility.

Genome medicine·2024

Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid.

Microbiology spectrum·2024

Single-cell multi-omics in IPF and COPD: from atlas to impact.

The European respiratory journal·2026

A phase 2a study with SPL84: A novel RNA-targeted approach to restore CFTR function in people with CF carrying the 3849+10 kb C→T mutation.

The European respiratory journal·2026

GLP-1-based therapies in lung diseases.

The European respiratory journal·2026

Sputum and oral microbiota profiles are associated with long COVID severity and phenotype post-hospitalisation: a UK multicentre, prospective cohort study.

The European respiratory journal·2026

Dysregulated NK cell phenotype in exacerbation-prone severe asthma.

The European respiratory journal·2026

Pleuroparenchymal fibroelastosis in a monogenic mitochondrial DNA depletion syndrome.

The European respiratory journal·2026

Bacillus subtilis is crucial for the normal growth of mycelium for Stropharia rugosoannulata.

Fungal biology·2026

Disseminated Blastomycosis With Pulmonary, Cutaneous, and Splenic Involvement in a Construction Worker: A Case Report.

Clinical case reports·2026

Lung Localization of Endosalpingiosis: Challenges of Rare Manifestation of Müllerianosis.

International journal of surgical pathology·2026

A novel serum four-biomarker biosignature and field-deployable colloidal gold strip for accurate identification of subclinical and active tuberculosis.

Expert review of molecular diagnostics·2026

Evolved differences in microglial cell biology between surface and cave populations of Astyanax mexicanus.

The Journal of experimental biology·2026

From Planktonic to Sedentary Lifestyle: Molecular Dissection of the Establishment and Maintenance of Mycobacterial Biofilm.

ACS omega·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us